Ampio Pharmaceuticals Inc... (AMPE)
0.00
null (null%)
At close: Jan 14, 2025, 8:00 PM
0.00
0.00%
Pre-market Nov 27, 2024, 10:02 AM EST
undefined% (undefined)
| Bid | n/a |
| Market Cap | 2.95K |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -10.66 |
| PE Ratio (ttm) | 0 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 878 |
| Avg. Volume (20D) | 1,172 |
| Open | 0.00 |
| Previous Close | undefined |
| Day's Range | 0.00 - 0.00 |
| 52-Week Range | 0.00 - 2.47 |
| Beta | undefined |
About AMPE
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requi...
Industry Biotechnology
Sector Healthcare
IPO Date Mar 31, 2010
Employees 6
Stock Exchange AMEX
Ticker Symbol AMPE
Website https://www.ampiopharma.com
